Azathioprine - Inflammatory bowel disease
You are here : Home > Formulary Search > Azathioprine - Inflammatory bowel disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Amber
Formulations :
- Oral suspension
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (Local)
Guidelines (Local)
Shared Care
Shared Care
Shared Care
Shared Care
PAD Profile
ChemicalSubstance :
Azathioprine
Indication :
Inflammatory bowel disease
Group Name :
Keywords :
thiopurines, IBD, UC, Ulcerative Colitis, Crohn's Disease
Brand Names Include :
Imuran, Jayempi
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
7
Other Indications
Below are listed other indications that Azathioprine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Inflammatory bowel disease.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed a local adaptation of the National Shared Care document, in reference to the routine monitoring of CRP (rather than ESR) in primary care for inflammatory indications
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)